| N-(4-Pyrrolidin-1-yl-piperidin-1-yl)-[4-(4-benzo[b]thiophen-2-yl-pyrimidin-2-ylamino)phenyl]carboxamidehydrochloride |
N-(4-Pyrrolidin-1-yl-piperidin-1-yl)-[4-(4-benzo[b]thiophen-2-yl-pyrimidin-2-ylamino)phenyl]carboxamidehydrochloride |
1186195-62-9 |
| Tipifarnib |
替吡法尼 |
192185-72-1 |
| 1-N-Boc-5-oxo-1,4-diazepane |
1-Boc-1,4-二氮杂-5-环庚酮 |
190900-21-1 |
| METHYL 2-FLUORO-3-OXOPENTANOATE |
2-氟-3-氧代戊酸甲酯 |
180287-02-9 |
| Zoledronic acid hydrate |
唑来磷酸一水化合物 |
165800-06-6 |
| 3-(Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid |
3 - (二氟甲基)- 1 -甲基- 1H-吡唑-4 - 羧酸 |
176969-34-9 |
| Roflumilast |
罗氟司特 |
162401-32-3 |
| SB 203580 |
4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑 |
152121-47-6 |
| Ivabradine hydrochloride |
盐酸伊伐布雷定 |
148849-67-6 |
| 5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one |
3-(6,7-二氢-1-甲基-7-氧代-3-丙基-1H-吡唑O-(4-3-D)-嘧啶-5 |
139756-22-2 |
| MG-132 |
MG132,蛋白酶体抑制剂 |
133407-82-6 |
| 1-Cbz-4-hydroxymethylpiperidine |
1-Cbz-4-羟甲基哌啶 |
122860-33-7 |
| BAPTA-AM |
BAPTA-AM |
126150-97-8 |
| N-Boc-N,N-bis(2-chloroethyl)amine |
N,N-双(2-氯乙基)氨基甲酸叔丁酯 |
118753-70-1 |
| Vadimezan |
2,5-己酮可可碱 |
117570-53-3 |
| Rebeprazole sodium |
雷贝拉唑钠 |
117976-90-6 |
| 7-BROMO-2,3-DIHYDROTHIENO[3,4-B][1,4]DIOXINE-5-CARBOXALDEHYDE 97 |
5-溴-2-(3,4-乙烯基双氧噻吩)甲醛 |
852054-42-3 |
| Foretinib (GSK1363089) |
N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 |
849217-64-7 |
| Tariquidar |
N-[2-[[4-[2-(6,7-二甲氧基-3,4-二氢-1H-异喹啉-2-基)乙基]苯基]氨基甲酰基]-4,5-二甲氧基苯基]喹啉-3-甲酰胺 |
206873-63-4 |
| 25-HYDROXYVITAMIN D2 |
25-羟麦角甾醇 |
21343-40-8 |
